Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnOrphan Medicine

Fanskya(mozafancogene autotemcel)

Fanconi Anemia

Marketing Authorisation Holder: Rocket Pharmaceuticals B.V.

INN: Mozafancogene autotemcel

Indication

 Treatment of paediatric patients with Fanconi Anaemia Type A

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Fanskya — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.